Market Overview
For the Quarter Ending September 2025 听
Doxylamine Succinate Prices in听North America
In the United States, the Doxylamine Succinate Price Index rose quarter-over-quarter in Q3 2025, driven by increasing production costs.
Producer Price Index increased 2.6 % year-over-year in August 2025, reflecting rising input costs for Doxylamine Succinate production.
Consumer Price Index rose 3.0 % year-over-year in September 2025, indicating higher operational costs for manufacturers.
Doxylamine Succinate demand was supported by robust 5.42 % year-over-year retail sales growth in September 2025.
A low unemployment rate of 4.3 % in September 2025 bolstered consumer confidence, supporting demand for OTC products.
Raw material inventories for chemical manufacturers continued to shrink in Q3 2025, impacting supply dynamics.
Organic chemical input costs experienced upward pressure in Q3 2025, contributing to higher Doxylamine Succinate expenses.
US chemical manufacturing activity appeared to contract in Q3 2025, affecting overall supply chain efficiency.
Natural gas prices experienced year-over-year spiking in Q3 2025, influencing energy feedstock costs.
Why did the price of Doxylamine Succinate change in September 2025 in North America?
Input and raw materials costs for chemical manufacturers increased during Q3 2025.
The Producer Price Index rose 2.6% year-over-year in August 2025, reflecting higher production expenses.
Shrinking raw material inventories for chemical manufacturers in Q3 2025 contributed to supply pressures.
听
Doxylamine Succinate Prices in听Europe
In Germany, the Doxylamine Succinate Price Index rose quarter-over-quarter in Q3 2025, driven by persistent high energy and raw material costs.
Doxylamine Succinate production costs faced upward pressure in Q3 2025, with ammonia prices rising and high energy costs challenging the industry.
Demand for Doxylamine Succinate was supported by increased pharmaceutical production in Germany during Q3 2025.
Germany's Manufacturing Index contracted in Q3 2025, reflecting a broader industrial slowdown and impacting overall chemical demand.
The Consumer Price Index increased by 2.4 % in September 2025, indicating rising operational costs and reduced consumer purchasing power.
Retail sales in Germany rose by 0.2 % in September 2025, suggesting stable consumer demand for Doxylamine Succinate in OTC products.
Ammonia supply in Europe tightened in Q3 2025 due to facility maintenance and increased power-sector offtake.
The Producer Price Index declined by 1.7 % in September 2025, primarily due to lower energy prices, offering some cost relief.
Why did the price of Doxylamine Succinate change in September 2025 in Europe?
Production costs increased due to rising ammonia prices and persistent high energy costs in Q3 2025.
Demand was supported by increased pharmaceutical production, despite a contracting Manufacturing Index in Q3 2025.
The Consumer Price Index rose 2.4% in September 2025, while the Producer Price Index declined 1.7%.
听
Doxylamine Succinate Prices in听APAC
In China, the Doxylamine Succinate Price Index fell quarter-over-quarter in Q3 2025, influenced by declining producer prices.
Doxylamine Succinate production costs decreased in Q3 2025, with the Producer Price Index falling -2.3% year-over-year.
Organic chemical intermediate costs, including phenol and acetone, declined in Q3 2025 due to oversupply.
Demand outlook was mixed; CPI fell -0.3% year-over-year, and consumer confidence was 89.6 in September 2025.
Retail sales increased 3.0% year-over-year, with unemployment at 5.2% in September 2025, supporting some spending.
Industrial production grew 6.5% year-over-year in September 2025, despite the Manufacturing Index contracting.
Chemical manufacturers faced inventory accumulation in Q3 2025, constraining their ability to maintain higher offers.
The Doxylamine Succinate price forecast suggests continued downward pressure from oversupply and reduced input costs.
Why did the price of DOXYLAMINE SUCCINATE change in September 2025 in APAC?
Producer prices fell -2.3% year-over-year in September 2025, reducing Doxylamine Succinate costs.
Inventory accumulation by manufacturers in Q3 2025 pressured Doxylamine Succinate pricing downwards.
Weak consumer demand, with a -0.3% CPI year-over-year in September 2025, impacted sales.
view historical insights
How We Can Help
果酱视频: Your Source for Real-Time Market News, Weekly Price Updates
Stay ahead of the competition with 果酱视频, the premier provider of
actionable market news. We offer real-time updates on prices, tracking and
reporting pricing trends, market news, and demand & supply for over 450
commodities.
Why choose 果酱视频? We go beyond just providing prices - we give you the
insights behind them. Our expert analysts not only deliver accurate price
data but also explain the exact reasons why prices have gone up or down.
This knowledge helps you make informed decisions and understand market
dynamics.
Planning your purchase at the right timing is crucial, and that's why we
provide price forecasts. Our forecasts help you anticipate market movements,
enabling you to optimize your procurement strategy and maximize cost
savings. Additionally, we track plant shutdowns to assess any risks
associated with supply disruptions. By keeping you informed about potential
disruptions, we empower you to proactively manage your supply chain and
mitigate any potential issues.
Our Analysts team comprises chemical engineers and experts with strong
backgrounds in economics, manufacturing, supply chain, and trading. With
offices in Houston, Cologne, and New Delhi, we provide a comprehensive view
of the global market. Our ground teams are based out of more than 50+ major
trading ports such as Houston, Shanghai, Busan, Rotterdam, Jebel Ali,
Antwerp, Hamburg, and more. This ensures that we have firsthand information
and insights on market activities, allowing us to deliver accurate and
timely reports.
Don't miss out on valuable insights! Keep your procurement teams informed and
empowered with 果酱视频's unparalleled expertise.
Subscribe 果酱视频 today for the latest market news and stay on top of
your game.
Product Description
Doxylamine Succinate is a pharmaceutical active ingredient (API) belonging to the class of ethanolamine-based antihistamines. Chemically, it is the succinate salt of doxylamine, a first-generation H1 receptor antagonist. It is synthesized through the reaction of doxylamine free base with succinic acid, producing a stable, crystalline salt suitable for medicinal formulations. The process ensures high purity, consistent potency, and favorable physicochemical properties required for oral administration.
The compound appears as a white to off-white crystalline powder, highly soluble in water and slightly soluble in organic solvents. It exhibits excellent chemical stability under standard storage conditions and retains its pharmacological activity over time. Its molecular structure enables effective binding to H1 histamine receptors, contributing to its sedative and anti-allergic properties.
Doxylamine Succinate is valued for its ability to alleviate allergy symptoms, induce sedation, and treat insomnia, making it a versatile therapeutic agent. Major applications include over-the-counter sleep aids, antihistamine formulations, combination cold and flu medicines, and anti-nausea products, where it serves as a key active component for symptomatic relief in various conditions.
